Skip to main content
2023 ACCP Annual Meeting Main banner
Final Program


Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.

Xiaoming Cui, PhD (she/her/hers)

Director, PK Sciences, Translational Medicine
Novartis Inst for Biomedical Research

Xiaoming Cui is a highly experienced clinical pharmacologist with over 20 years of industry experience, spanning drug discovery to late phase clinical development. She began her industrial Career in early phase drug discovery and development at Schering-Plough. For the past 13 years, she has focused on clinical development of oncology drugs at Novartis, leveraging her extensive expertise in clinical pharmacology, ADME/PK/PD, translational science, biopharmaceutics, and regulatory science. Dr. Cui is passionate about developing safe and effective medications for patients and promoting the importance of clinical pharmacology in drug development.
Dr. Cui received a Ph.D. in Biochemistry and Molecular Biology, with a focus on drug metabolizing enzymes, from MD Anderson Cancer Center/UT Health Graduate School of Biomedical Sciences, as well as an M.D. from Capital University of Medical Sciences in Beijing, China.

Presentation(s):